MedTrace Logo

Determination of Gentamicin Dosing in Neonatal Patients

NCT00198601 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2018-04-20

No results posted yet for this study

Summary

The purpose of this study is to determine what dosage of gentamicin for use in one-time administration device (Uniject) is appropriate.

Conditions

Interventions

DRUG

Gentamicin in Uniject Pre-filled syringe

Sponsors & Collaborators

  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • Gary Darmstadt, MD · Johns Hopkins Bloomberg School of Public Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Minute
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Primary Completion
2005-07-31
Completion
2005-07-31

Countries

  • Bangladesh
  • India
  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00198601 on ClinicalTrials.gov